Benjamin J. Daverman

Ben Daverman is a Managing Director and the Co-Head of the Healthcare group at GTCR.

Ben joined GTCR in 2008. Prior to joining GTCR, he worked as a Venture Capitalist at Alta Partners, as well as an Investment Banking Associate at JMP Securities and an Analyst in the Mergers & Acquisitions group at J.P. Morgan (formerly Hambrecht & Quist). He holds an MBA from the Wharton School at the University of Pennsylvania and a BA in history, magna cum laude, from Colgate University. Ben also holds a master’s degree in biotechnology from the School of Applied Sciences & Engineering at the University of Pennsylvania.

Ben is currently a Director of TerSera Therapeutics, Albany Molecular Research, Antylia Scientific, Corza Health, and Maravai LifeSciences. He was previously on the boards of Actient Pharmaceuticals, Cord Blood Registry, Crealta Pharmaceuticals, Devicor Medical Products, GeneraMedix, Sterigenics, and XIFIN.